- dentalcorp Holdings Ltd DNTL coverage has been assumed with a Buy recommendation and a price target of C$21 by Desjardins analyst Gary Ho.
- The analyst says the recently announced dental care proposal for low-income Canadians as a slight benefit for the company.
- The analyst sees the business model offering downside protection through >80% recurring patients/revenue, a non-discretionary spend and cash-pay arrangement with minimal credit risk, as well as upside growth from M&A and organic growth.
- The analyst states that DNTL’s management team has a successful M&A track record of acquiring, integrating, and retaining >180 practice additions in the past three years despite COVID-19 restrictions.
- Price Action: DNTL shares are trading lower by 1.36% at C$15.26 on TSX on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
